Evaluation of localized and systemic immune responses in cutaneous leishmaniasis caused by Leishmania tropica: interleukin-8, monocyte chemotactic protein-1 and nitric oxide are major regulatory factors.
(73/139)
(+info)
Therapeutic glucocorticoid-induced TNF receptor-mediated amplification of CD4+ T cell responses enhances antiparasitic immunity.
(74/139)
(+info)
Risk factors for acute kidney injury in visceral leishmaniasis (Kala-Azar).
(75/139)
(+info)
A retrospective study of intravenous sodium stibogluconate alone and in combinations with allopurinol, rifampicin, and an immunomodulator in the treatment of Indian post-kala-azar dermal leishmaniasis.
(76/139)
(+info)
A randomized controlled trial of local heat therapy versus intravenous sodium stibogluconate for the treatment of cutaneous Leishmania major infection.
(77/139)
(+info)
Leishmania donovani isolates with antimony-resistant but not -sensitive phenotype inhibit sodium antimony gluconate-induced dendritic cell activation.
(78/139)
(+info)
Flow cytometric screening for anti-leishmanials in a human macrophage cell line.
(79/139)
(+info)
Regulatory role of nitric oxide in the reduced survival of erythrocytes in visceral leishmaniasis.
(80/139)
(+info)